NCT03656562ianalumabsystemic lupus erythematosusSLESRI-6SRI-4
…s This multi-center, randomized, parallel-group Phase 2 study ( NCT03656562) enrolled patients with anti-nuclear antibodies >=1:80, 11 ACR …
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT03656562 ×
NCT03656562
This funder is selected. Its supporting articles are shown below.